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TCP: Tri-calcium phosphate 
CMC: Carboxymethyl cellulose 
IgG: Immunoglobulin G 
Micro-CT: Micro computed tomography 
SAL: Sterility assurance limit 
PCL: Poly caprolactone 
PLGA: Poly(lactic-co-glycolic acid) 
PLLA: Poly-L-lactide  
HA: Hydroxyapatite 
MIP: Mercury intrusion porosimetry 
SEM: Scanning Electron Microscopy 
XRD: X-Ray diffraction 
SBF: Simulated body fluid 
PBS: Phosphate buffered saline 
TRIS: Tris hydroxymethyl aminomethane 
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Autograft:  Patients own tissue or organ used for surgical reconstruction. 
Allograft: The tissue or organ transplanted to the patient from a genetically non-identical donor 
of same species. 
Xenograft: The tissue or organ transplanted from one species to another. 
Osteoconduction: Bone growth on surface or into pores 
Osteoinduction: Undifferentiated cells stimulated to form bone forming lineage 
Osteogenesis: Contact between living bone and implant without growth of fibrous tissue at bone 
implant interface 
Inflammation: Complex biological response to any foreign body 
Biocompatibility: Ability of material to resist unwanted immunological reactions when 
implanted in-vivo 
Biodegradabilty: Ability of a material to disintegrate naturally 
Stress shielding: Mismatch between the young’s modulus of bone and implant which leads to 
uneven distribution of load 
Bioactivity: Ability of a material to initiate biological reactions when implanted in body 
Micropores: Pores ranging in the size less than 50µm 
Macroporosity: Pores ranging in the size greater than 50 µm to few millimeters 
Osteogenesis: Bone healing by cell groweh and differentiation 
Gas foaming: Introducing pores by gas entrapment method 
Composite: Material composed of two or more compounds 
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Anisotropic: Variation in properties with respect to direction 
Dispense: Force through an orifice by applying pressure 
Pore size distribution: The wide range of pores sizes in a material 
Compressive strength: Ability of a material to withstand load which tends to reduce its size 
Surfactant: A substance which reduces surface tension between two liquids or a liquid and a 
solid 
Interconnected pores: Pores which are connected through inner channels 
Vacuum: An enclosed space without matter 
Angiogenesis: Process of formation of blood vessels 
Power law: Correlation between stress and plastic strain 
Bone remodeling: Formation of new bone tissue by replacing the old one. 
Regression: Statistical method to derive a relationship between dependant and independent 
variables 
Permeability: Ability of a membrane to allow diffusion of materials 
Vascularization: Process of formation of blood vessels 
Biomineralization: Process by which bone like mineral phase is formed 
Phase transformation: Change of material from one phase to another due to variation in 
temperature 
Strain hardening: Increase in strength of material by plastic deformation 
Intrusion: Forceful entry of a fluid inside pores due to pressure 
Extrusion: Forceful removal of fluid from pores by applying pressure 
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This study reports the fabrication of 3D constructs using Tri-calcium phosphate/carboxymethyl 
cellulose composite with alginate. Microporous scaffold fibers were developed by incorporating 
gas bubbles within fibers, stabilizing it with surfactants, and subsequently removing the gas by 
vacuum treatment. The prepared paste was dispensed through a specially designed sieve plate by 
applying pressure and extruded in a calcium chloride/acetic acid bath. Gas is evolved as a result 
of reaction between sodium bicarbonate in paste and acetic acid in solution. The porosity of the 
fiber is tuned using 0.9, 1.8 and 3.6 weight% sodium bicarbonate (NaHCO3). The processed 
fibers were characterized using scanning electron microscopy (SEM) and mercury intrusion 
porosimetry (MIP). The morphology of the scaffold was characterized using scanning electron 
microscopy (SEM). From SEM results pore morphology was found to be better in scaffolds with 
0.9 wt% NaHCO3 as it revealed an interconnected structure. Mercury intrusion porosimetry 
results showed an increase in pore volume with increasing concentration of NaHCO3.  A detailed 
study on the mechanical properties of the constructs was carried out to evaluate the compressive 
strength. In-vitro bioactivity studies were carried out in simulated body fluid (SBF) for 2/4 
weeks. The study showed that the scaffold provides favorable substrate conditions to form bone 
like mineral HA phase, which plays a significant role in osteointegration. 
 
Keywords: Tri-calcium phosphate, composite, Microporous scaffold, mechanical strength, 
simulated body fluid, bioactivity 
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Repairing bone defects caused by fractures, trauma, surgery, congenital malformation, tumors 
and infections is a major challenge faced by orthopaedic surgeons. Recent studies show that 
around 800,000 people undergo bone graft surgery per year [1]. The various grafting 
techniques used for bone reconstruction are autograft, allograft and xenograft [2]. Autografts 
cause no immunological reactions and have high success rates. However, it involves a second 
surgical procedure which is time taking and increases surgical complications. But, graft 
rejection and disease transmission is a major concern with allograft tissue [3]. Various 
sterilization techniques are used to render the allografts disease-free, but studies show that 
sterilization might affect the material property of the grafts [4]. Xenografts, provide large 
quantity of animal tissue for transplantation but poses a major risk of viral and bacterial 
infections from other species [5]. The properties of bone grafts which assist in bone healing 
are listed below (Table 1). 
Table 1: Types and properties of bone grafts  
 
Inspite of the various advantages, bone grafts have got significant limitations, which leads to 
the use of bone graft substitutes. Bone graft substitutes can be broadly classified into 
Graft type Bone healing properties 
Autograft [6] Osteogenic                                                                                                         
Osteoinductive                                                                                                            
Osteoconductive 
Allograft [7] Osteoinductive                                                                                         
Osteoconductive 
Xenograft [3] Osteoconductive     
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osteoconductive, osteoinductive and osteogenic (Fig 1). These three are most important 
properties which should be possessed by an ideal bone graft substitute (Fig 2).       
                            
Figure 1: Broad classification of bone graft substitutes [8] 
Bone scaffolds provide a structural matrix for cell attachment and tissue repair. The 
artificially fabricated scaffolds should mimic the native extracellular matrix in body, by 
giving a strong structural support and providing a proper environment for growth and 
anchorage of cells [9]. This also increases cell adhesion, cell spreading and cell growth on the 
surface of the scaffold which is a very crucial step in tissue engineering of scaffolds. The cell 
spreading and bone cell ingrowth on the scaffold surface plays a very crucial role in tissue 
engineering applications. The ideal properties of scaffolds are listed below. 
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Figure 2: Three most important properties possessed by an ideal bone graft substitute 
 
1. Biocompatibility  
The property of material by virtue of which it prevents unwanted immunological reactions 
when implanted inside body is known as biocompatibility. Such a material does not release 
any toxic or harmful product causing chronic inflammation or tissue necrosis [10]. When an 
implant is introduced in body it involves a plethora of immunological reactions. Initially 
blood reacts with implant surface and results in a temporary matrix which initiates blood clot 
Thereafter, acute and chronic inflammation occurs in a sequential manner. Neutrophills and 
polymorphonuclear leucocytes are released during acute inflammation whereas monocytes 
and lymphocytes are released during chronic inflammation. 
       
  IDEAL SCAFFOLD 
Osteoblasts Osteocytes 
  Scaffolds     Factors     
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Table 2: Different types of biocompatibility tests[11] 
The adsorbed proteins activate the complement system which is the first line of defense. It 
triggers immune cell activation immediately after invasion of a foreign body. The foreign 
In-vitro testing In-vivo testing 
FDA Tests Cell culture Cell culture Blood 
response 
Others Tissue 
compaibility 
Implantation 
Implantation Types of 
Cells 
Tests Coagulation Bacterial 
adheshion 
Subcutaneous Subcutis 
Hemolysis Fibroblasts Replication Complement 
tests 
Protein 
adsorption 
Intramuscular Blood 
Acute 
systemic             
Toxicity 
Monocyte Proliferation Platelet 
adhesion 
and 
activation 
Calcification Intraperitoneal Bone 
Pyrogenecity Macrophage Adhesion Fibrin 
adhesion 
and 
activation 
Mineralisation  Cornea 
Mutagenicity Endothelium Density Erythrocyrte   Reproduction 
 Osteoblast Morphology SEM 
observations 
  Heart 
 Urethelial 
Cells 
Phenotype    Arteries 
     Gingival 
Cells 
Receptor 
expression 
    
 Epithelial 
Cells 
Secretion 
Molecules 
    
 
 Reproductive 
Cells 
mRNAexpression     
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body giant cells and macrophages lead to damage of material surface and ultimately cause 
device failure [12]. Different methods are used to check the biocompatibility of materials. The 
most commonly used methods are shown in Table.2 . Surface chemistry of biomaterials is 
found to influence the biocompatibility of implant. Hydrophobicity of implant surface induces 
protein adhesion on implant surface. These adsorbed proteins in turn cause coagulation and 
inflammation. Various physical and chemical surface modification techniques are used to 
reduce protein adhesion and improve biocompatibility [13]. Functional groups like carboxyl 
(–COOH), hydroxyl (-OH) and amine (-NH2) alter the surface of implant and promote cell 
proliferation and differentiation [14]. Apart from the materials intrinsic property, 
biocompatibility of an implant also depends on external factors like processing and 
sterilization. 
 
2. Biodegradability  
It is the property by virtue of which an implant maintains its mechanical properties for 
required period of time in body followed by absorption and excretion by the body. Earlier 
permanent implants were used but it involved many disadvantages like: 
 1) Inflammatory reactions  
2) Irritation 
3) Post surgical problems 
4) Stress shielding 
5) Corrosion 
6) Secondary surgery.  
These problems related to permanent implants led to the use of biodegradable implants which 
act as a temporary matrix for growth of tissue and undergoes slow dissolution inside the body. 
Around 95% of patients have preferred biodegradable implants for fracture fixations as 
compared to permanent implants as the former avoids unnecessary surgical complications 
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[15]. The rate of degradation of implant should match the tissue growth in order to maintain 
the mechanical integrity in a controlled manner [16]. Biodegradable materials used in 
orthopaedic applications can be broadly classified into natural and synthetic materials. Natural 
materials include collagen, gelatin, polysaccharides (alginate, chitosan, agarose, hyaluronic 
acid) and fibrin. Commonly used synthetic materials include Poly(a-Hydroxy Esters), Poly(e-
Caprolactone), Poly(Orthoesters), Poly(Anhydrides), Poly(Ethylene Glycol)-based materials, 
Poly(Amino Acids) and fumarate-based polymers [17].  Biodegradable implants show two 
types of events on introduction within body. One is the short-term or immediate foreign body 
reaction and the second one is long-term event. Former one involves recruitment of mast 
cells, histamine and proteins on the site of implantation. The later involves chronic 
inflammation. Biodegradable implants should be biocompatible in order to exist in body for 
long time without any unwanted immunological reaction [18].                            
 
3.Mechanical strength 
An implant should be strong enough to withstand the weight of body as well as the muscle 
force exerted by the skeletal structure [19]. These forces exerted on implant cause stress-strain 
reactions on the bone-implant interface and lead to implant breakage and failure. When an 
implant is attached to a bone the load which was totally carried by bone initially is now 
distributed between the implant and bone [20]. As a result the bone is shielded from the stress 
i.e the stress induced in bone is reduced. This phenomenon is known as stress shielding and 
bone resorption occurs simultaneously [21]. Stiffer the implant more is the stress shielding 
effect. According to Wolff’s law: “bone adapts to the different loads to which it is subjected” 
i.e bone undergoes remodeling in order to adjust to the load applied on it [22-23]. So, the 
primary goal in fabrication of an implant is that it should remain mechanically stable in long 
run. The implant should be designed in such a way that the stress should be homogenously 
distributed between the implant and bone thus, preventing bone atrophy and fracture. 
Mechanical strength details of human bone are given in table below (Table 3). 
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Table 3: Mechanical properties of human bone [24] 
Bone Type Compressive 
strength 
(MPa) 
Flexural 
Strength 
(MPa) 
Elastic 
Modulus 
(GPa) 
Porosity  
(%) 
Cortical bone 130-180 135-193 12-18 5-13 
Cancellous bone 4-12 NR* 0.1-0.5 30-90 
 
 
 
4. Bioactivity 
It is defined as the bone bonding ability of an implant. The term was first introduced in 1971 
by Larry Hench after the invention of bioglass. A bioactive material triggers a biological 
reaction at the bone-implant interface and leads to the formation of a bond between implant 
and bone. Also a bioactive material is found to initiate osteogenesis (new bone growth). These 
materials can be divided into two classes (Class A and Class B) based on bioactivity index 
(Ib). Bioactivity of a material is related to the time taken for more than 50% bonding between 
bone and interface ( t0.5bb ) by the following expression [25-26] 
Ib= 100/ t0.5bb ,  
If, Ib >8 = Class A  
0<Ib <8 = Class B 
Class A materials bind to both hard and soft tissue and show both osteoinduction and 
osteoconduction. Whereas, class B materials bind to hard tissue only. Within 20 days a strong 
bond is developed between the bioactive implant and bone provided the gap between implant 
and bone is small [27]. In-vitro bioactivity tests are performed in simulated body fluid. 
Simulated body fluid has got ionic concentration similar to human blood plasma. Ceramics 
when immersed in SBF solution show apatite layer formation (Fig3). This apatite formation 
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in-vitro is correlated to bone formation in-vivo [28]. Different bioactive coatings are 
employed on metallic implants in order to improve the osteointegrative property. 
 
Figure 3: Mechanism of apatite layer formation in ceramic on immersion in SBF [28] 
Bioactive glass coating is the most popular among them [29]. In case of calcium phosphates 
this happens through material dissolution and formation of apatite similar to the bone mineral 
phase on the surface of the implant.  
 
5. Porosity 
 It is an important structural feature of a scaffold. Pore is defined as the void space present in 
scaffold which allows penetration of cells (Fig. 4) [30]. A collection of pore is known as 
porosity. Pore size is a major factor in fabrication of scaffolds. Since mammalian cells are in 
the range of 10-20µm, macropores greater than 50µm are generally sufficient for tissue 
functions [31]. However, for bone-ingrowths macropores greater than 300µm is usually 
considered. Although macroporosity is a primary factor which influences osteogenesis, 
microporosity of a scaffold is also equally essential. Micropores less than 10µm increases 
surface roughness which inturn increases surface area and allows apatite precipitation and 
protein adsorption [32]. Porosity of a scaffold influences other scaffold properties like 
mechanical strength and.With increase in porosity the mechanical strength of scaffold 
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decreases and degradation rate increases degradability [33-34]. In addition to porosity pore 
interconnectivity is another important factor in scaffold fabrication [35]. Unless the pores in 
scaffold are properly linked, cell migration would not occur which would hinder proper cell 
growth. 
 
 
Figure 4: Bone integrating on a porous scaffold 
Further, a proper distribution of cell nutrient and removal of waste is facilitated by 
interconnected pore structure. Various techniques have been used for scaffold porosity 
determination. Theoretical methods include Archimedes method and liquid displacement 
method. Here the scaffold is immersed in a liquid and the change in volume is noted down. It 
is a quick and easy method to determine porosity. However, pore morphology, 
interconnectivity and pore size cannot be determined by this method. Scanning electron 
microscopy is used to determine the pore morphology and pore size. Mercury intrusion 
porosimetry is another technique which is used to determine porosity, pore volume and pore 
tortuosity. Micro-CT is a very latest and advanced technique which is used to determine 
porosity, pore volume and pore interconnectivity [36] 
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6. Sterilizability 
Sterilization is the process that kills all types of microbes and living organisms present on the 
surface of a material. An implant should be sterile so that it can be placed inside body without 
any reaction from the host body. Disinfection will kill most of the vegetative microorganisms 
but resistant bacterial spores are not affected by the treatment. The most commonly used 
disinfectants such are alcohol, iodophors, quaternary ammonium and phenolic compounds are 
not accepted as good sterilizing agents for surgical purposes. Sterility is determined by a limit 
known as sterility assurance limit (SAL). It is defined as the probability that an implant 
remains nonsterile after placing inside body. The accepted limit of SAL is 10
-6
 [37]. Various 
techniques used for sterilization are as follows: steam sterilization, gamma irradiation, 
ethylene oxide sterilization, hydrogen peroxide gas plasma treatment, peracetic acid 
treatment, dry heat sterilizers, liquid chemicals, microwave and formaldehyde steam [38] 
Steam sterilization is commonly used on heat resistant materials. Materials that are heat labile 
use other alternative low-temperature sterilization techniques. So, depending on the material 
type the most appropriate sterilization technique is chosen.  
 
 
7. Manufacturability 
The prepared scaffold should be made of such a material that it can be easily fabricated. 
Generally scaffolds are tested in laboratory scale and the preparation and other methodologies 
applied are done in pilot scale. So, the constituents used and the method of fabrication should 
be simple and easy to fabricate even in large scale. As the main aim is to use the scaffold for 
clinical purpose very complicated methods might be difficult to scale up. Sometimes the 
result obtained in pilot scale does not match that in large scale. So, the material chosen 
initially should be done in such a way that it is feasible when used in large scale use.  
The industrial application is a must as it is the final goal of any product manufacture. 
 
All the above mentioned properties should be present in an ideal scaffold for proper cell 
growth, adhesion and for application in clinical applications and applications in industrial 
level. 
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The goal of this research is to fabricate a three dimensional, mechanically stable porous tri-
calcium phosphate-carboxymethyl cellulose alginate scaffold by using a simple, cost-effective 
set-up made from a reusable syringe. The purpose of fabrication of these scaffolds is to 
provide oxygen and nutrients to flow through the open interconnected pores created by gas 
entrapment in the fibers in order to promote osteoblasts. The mechanical properties of tri-
calcium phosphate scaffolds were increased by using carboxymethyl cellulose. An optimum 
porosity was tried to obtain by using different concentrations of sodium bicarbonate in order 
to tailor the porosity. The biological properties are based on the structure and mechanical 
properties of scaffold.  
 
Micropores are incorporated in the fibers by entrapment of gas. The gas is produced by 
chemical reaction between acetic acid and sodium bicarbonate. The evolved gas is then forced 
to come out by vacuum treatment. Thus open interconnected pores are formed. This basically 
allows proper nutrient supply. Thus macroporosity in between fibers and microporosity in the 
fibers is achieved in the fabricated scaffolds. Also a simple cost-effective set up was formed 
for extrusion of paste in order to form fibers. A 10 ml syringe was designed in such a way 
with a sieve plate and a hole pattern in the syringe head. This set-up was used manually by 
application of pressure on the scaffold fiber. The height of the scaffold was adjusted by using 
a known volume of paste. 
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Calcium phosphates have been used widely to fabricate bone graft substitutes. Tri-calcium 
phosphates have been used in orthopedic applications as it is a rich source of calcium and 
phosphorous. It is easily absorbed by body and shows high biocompatibility and bioactivity 
[39]. These materials allow adhesion of growth factors and protein on their surface. 
Promotion of osteoblast adhesion makes calcium phosphates osteoconductive and hence it is 
widely used to repair bone defects and injury [40]. 
Table 4: Different types of techniques used to fabricate 3D porous scaffold 
Technique used Description 
Gas foaming[41] Gas is infused into polymer to create pores 
Fiber bonding[42] Formation of an interconnected mesh with 
polymer fibers 
Phase separation[43] Removal of solvent phase to form porous 
scaffolds 
Freeze drying [44] Polymer, solvent and water mixed together 
and exposed to liquid nitrogen. Water 
molecules are removed to create pores.  
Porogen leaching [45] Salt is dissolved in polymer to form pores 
Additive manufacturing process: [46]  
a) 3D printing 
b) Solid free form fabrication 
c) Rapid prototyping 
Scaffold is fabricated from a computer aided 
design 
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Similarity with inorganic phase of bone has led to the use of tri-calcium phosphates as 
suitable candidate for fabrication of 3-D scaffolds [46]. Although there are various views 
regarding the property that an ideal 3-D scaffold should posses, porous architecture has 
always remained a primary need. Porosity initiates bone tissue ingrowth and assists in vivo 
osteoblast growth and proliferation. Macroporosity initiates osteogenesis. But interconnection 
between pores plays a vital role in bone vascularization and bone remodeling [47-48]. 
Microporosity (< 20µm) improves bone ingrowth by increasing protein adsorption on scaffold 
surface [49]. The combination of macro, micro and interconnected porosity together helps in 
providing nourishment for the formation of new bone. Microporous hydroxyapatite scaffolds 
have shown four times more bone growth and bone contact with implant compared to normal 
scaffolds post healing [50]. Different techniques are used to fabricate porous 3D scaffolds. 
The common techniques used are listed in Table 4.  Gas based techniques are used compared 
to other techniques as it does not involve use of toxic solvents and allows proper dispersion of 
gas bubbles throughout the polymer. 
 
Table 5: Different gas based techniques used to fabricate porous scaffold 
Technique Polymer used 
Gas foaming and selective polymer extraction PCL, PLGA 
Foaming by in-situ generation of gas PCL 
Foaming through the insufﬂating of an inert 
gas 
Alginate, gelatin, PLLA 
CO2-water emulsion templating Gelatin, hyaluronic acid, chitosan, alginate 
Dense gas CO2 and a cosolvent Gelatin 
Using high pressure CO2 during crosslinking Elastin, chitosan 
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Different gas based techniques used to fabricate porous scaffold are shown in Table 5  [51]. 
Also the porosity of scaffolds directly influences its mechanical property. Study shows that 
mechanical strength increases with decrease in porosity [52]. However higher porosity and 
pore size result in successful bone ingrowth into scaffolds but decreases the mechanical 
strength [53] 
Scaffolds that can be used in repairing load-bearing bone defects or other large defects, is the 
current requirement. However, the particular mechanical need of the scaffolds studied in 
repair of such defects, from the very start of implantation to total healing is still to be 
understood. The materials and their respective mechanical properties are still to be clear. The 
required properties such as strength and stiffness have been explained in the literature in many 
ways and different ways have been taken in order to design specific mechanically stable 
structures. A number of literatures have shown bone scaffold properties should be similar to 
those of natural one [53].  In order to achieve a scaffold with optimum mechanical strength 
the change in properties with respect to degradation should also be considered. The 
degradation rates also play a very critical role as a processing parameter in scaffold 
fabrication. Many studies took a totally different approach and optimized scaffold pore 
structure such that the scaffold characteristics matched that of native bone.  Calcium 
phosphate is a perfect material for use in bone repair. They have strength similar to bone and 
they exist in various forms which can be suitably used according to the clinical requirement.  
The only problem faced in using this material is the load bearing application and the inherent 
property of brittleness of the material. At present, the problem of breakage is being studied. 
Although tri-calcium phosphates are used popularly in implant applications they show low 
mechanical strength [54]. These exhibit natural brittleness and are not suitable for use in load 
bearing sites. Various methods have been employed in order to increase the strength of 
calcium phosphate scaffold. A second phase introduced in the ceramic matrix increases its 
stability [55]. Introduction of polymers in tri-calcium phosphate (TCP) powder has also found 
to increase mechanical property. PLGA, PMMA, polypropylene and polycaprolactone are 
common polymers which have been used to fabricate TCP composite scaffolds [54]. At 
present ceramic based polymeric scaffolds are being developed to provide proper matrix for 
bone tissue engineering [56]. It has been seen that ceramic based grafts are not suitable for 
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soft tissue growth when compared to polymeric substitutes, so synthetic and natural polymers 
are added to ceramics in order to improve its properties [57]. These composite scaffolds are 
considered as the present choice for bone replacements as they mimic natural conditions and 
allow cell prolifereation and differentiation in-vivo [58]. Carboxymethyl cellulose is a water 
soluble cellulose derivative which has been used to increase the compressive strength of 
materials [59-60]. It is a biodegradable biocompatible polymer which has the capability of 
chelating with the calcium ions in the hydroxyapatite. This induces cross-linking and makes it 
a suitable biopolymeric matrix. Nanocomposites of carboxymethyl cellulose (CMC) and HA 
have been used to fabricate 3D load bearing bone grafts [61]. CMC has been used in 
composite preparations due to its low cost compared to other naturally derived polymers and 
its excellent biological properties.  In bone tissue engineering, different materials have been 
used in bone repair and replacement. These biomaterials are of several types like: metals, 
ceramics, polymers, and composites. An ideal scaffold material which should be used in 
tissue engineering should meet certain properties in order to match that of host tissue 
environment. Good osteoinductive, osteoconductive properties, biodegradability and 
biocompatibility is a basic requirement.  Along with that in addition, porosity, 
interconnectivity and microstructure is also considered for bone repair. It is very challenging 
to find a porous structure with suitable pore size as well as mechanical properties. Various 
fabrication techniques have been used in manufacture of ceramics in biomedical applications 
However, none of the methods have completely satisfied the current necessity. 
Studies show that hydroxyapatite (HA) and other calcium phosphate (CaP) ceramics   help in 
formation of bone-like apatite layer on the surface. The degradation of CaPs have a strong 
correlation with bioactivity. The dissolution process is is linked to the precipitation of apatite 
like precipitation on the surface of the implant which is similar to that of bone. The 
degradation rate for CaPs is  Comparatively slower as compared to polymers this helps in 
maintaining a balance between degradation and bone growth. Different compositions of 
calcium phosphates have been used with chemical compositions of Ca5(PO4)5OH and a 
calcium to phosphate ratio of 1.67. 
There are different types of scaffolds which have their own advantages and 
disadvantages. The extracellular matrix in our body is composed of proteins like laminin, 
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collagen etc. These are fibrous in nature and allow cell adhesion and proliferation in-vivo. In 
order to mimic the extracellular matrix scaffolds are fabricated in such a way that they 
resemble the micron sized fibrils inside the body. Compared to the 2D scaffolds where the 
cells only attach to the scaffold surface, fibrous scaffolds allow proper spreading and adhesion 
of cells on to each of the fiber surface. This increases the surface area and in turn the diffusion 
of nutrients and nutrient availability is also increased compared to the 2D scaffolds [62]. The 
number of cells is also found to be higher in fibrous 3D scaffolds compared to others thus 
initiating faster bone healing and remodeling. Anisotropic properties are exhibited by the 
fibrous scaffolds thus allows proper cell orientation [63]. Studies show that the cell signaling 
and other cellular functions as well as cell differentiation and proliferations differ in 3D 
scaffolds compared to 2D ones. Also the arrangement of fibers and the microstructure plays a 
very important role in cell and tissue engineering [64]. Polymers have been found to have 
good degradation rate and they can be removed easily from body as metabolic waste after 
complete degradation. PLGA and PCL have been used successfully in scaffold fabrication and 
have found to show excellent degradability [65]. Polymeric scaffolds undergo degradation by 
ester bond breakage [66].  
In this study in order to fabricate a three dimensional mechanically stable porous 
scaffolds which are suitable for bone tissue engineering, TCP-alginate CMC composite was 
used and various tests were carried out to evaluate its properties. The scaffold fibres were 
formed as a result of forced extrusion of TCP-CMC and alginate solution into a CaCl2-Acetic 
acid mixture. The fibres thus obtained were compressed a known dimension and these 
cylindrical scaffolds were vacuum treated. This resulted in release of CO2 and a porous 
scaffold was formed. This resulted in release of CO2 and a porous scaffold was formed. Gas 
entrapment in the scaffold resulted in micro porosity in fibers. Subsequently, the vacuum 
treatment led to form an open interconnected porous network. Different ratios of alginate 
solution and TCP-CMC powder were mixed together to study the extrusion of the paste 
through the syringe. 
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A simple cost-effective set-up was made for extrusion of scaffold fibers. A 10 ml, 
single use (DISPO VAN) syringe was taken. The tip of the syringe following the barrel part 
was cut using a junior hacksaw. A thick circular plastic sheet with same diameter as the cut 
portion was taken and pattern of holes similar to a sieve plate was made on it. The holes were 
0.70 mm in diameter and 7 such holes were made in the circular sheet (Fig. 5 (a)). The sheet 
was then sealed to the syringe tip. The prepared set-up was fitted to a burette stand as shown 
in Fig. 5 (b). 
 
                        
Figure 5. Schematic for preparation of 3D scaffold (a) Hole patterns on the syringe head,  
(b)Setup for preparation of 3-D scaffolds 
Sodium alginate 2wt% (Sd-fine chem limited) solution was prepared in distilled 
water., SPAN 80 1 wt % (Loba Chemie) is taken as surfactant and three different 
concentrations of sodium bicarbonate (RANKEM) (0.9, 1.8 and 3.6 wt%) were added to the 
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alginate solution and stirred for 30 minutes till the volume doubled itself. The sample codes 
for three different compositions are listed in Table 6.  
 
Table 6: Sample codes for three scaffold compositions 
Sample code Alginate (wt%) SPAN 80(wt%) NaHCO3 
(wt%) 
TCP:CMC 
0.9_TCA 2 1 0.9 1:1 
1.8_TCA 2 1 1.8 1:1 
3.6_TCA 2 1 3.6 1:1 
 
This was followed by addition of appropriate amount of tri-Calcium orthophosphate, 
Extra pure (TCP) and carboxymethyl cellulose sodium salt (CMC) (both from HIMEDIA) to 
the prepared alginate solution. Different ratios of alginate solution and TCP-CMC powder 
were formulated to study extrusion through the experimental set-up. The composition of 0.4 
% by weight of alginate solution to TCP-CMC powder was found to be suitable as the 
suspension could easily dispense through the holes of the syringe set-up.  
A known volume of prepared suspension was loaded in the syringe set-up and 
dispensed into a cylindrical mould containing calcium chloride (CaCl2) (RANKEM)-acetic 
acid (HIMEDIA) solution. A 0.4 M CaCl2 solution was prepared in distilled water for fast 
setting of scaffold fibers. 10 % (v/v) acetic acid was added to the prepared CaCl2 solution. 
The fibers were directly dispensed through the set-up by manually applying pressure on the 
syringe plunger. The deposited fibers were pressed down to a particular height and the 
cylindrical scaffold was kept in vacuum overnight. The vacuum treated sample was then air 
dried. The steps used for preparation of scaffold are shown in Fig 6 and Fig 7. 
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Figure 6: Schematic representation for preparation of composite suspension and scaffold 
fabrication 
 
 
 
Sodium alginate 
solution (2wt %) 
Alginate solution with SPAN 80 
and NaHCO3 (stirred for 30 mins) 
Composite suspension (TCP and 
CMC added to form a paste) 
Paste dispensed in acetic 
acid-CaCl2 bath 
Manually pressed down 
to desired height 
Wet scaffold with closed interconnected pores 
Plunger Syringe-set up 
Vacuum chamber 
Pump 
Scaffold placed in vacuum chamber (24hr) Scaffold with open interconnected pores 
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Figure 7: Preparation of composite suspension and scaffold fabrication in laboratory. 
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 The morphology of scaffold fibers was analyzed using scanning electron microscopy 
(SEM) (JEOL JSM-6480LV). The porosity of the scaffold fibers were quantified using 
mercury intrusion porosimetry (MIP) (Quantachrome Corporation). The pressure was varied 
from 0.5 to 29,000 psi. The contact angle between mercury and the sample surface was taken 
as 140° and surface tension of mercury was taken as 480erg/cm
2
. Pore diameter, pore size 
distribution and percentage of porosity were determined. 
The scaffold consists of both macropores (formed between the fibers) and micropores 
(formed in the fibers). The overall porosity was determined using the liquid displacement 
method. Ethanol was used as the displacement liquid as it easily penetrates into the scaffold 
pores and is a non-solvent of polymers. A dry sample of weight W was immersed in a known 
volume of ethanol (Va). It was immersed in solution for 5-10 minutes and vacuum was 
applied to force the ethanol into the pores of scaffold. The new volume of ethanol (Vb , 
volume of ethanol and ethanol-saturated scaffold) was recorded. The ethanol-saturated 
scaffold was removed and the residual ethanol volume (Vc) was measured. The porosity of 
scaffold was measured using the following equation (Eq.) [66]. Samples were tested in 
duplicates and the average was taken and calculated. 
   
.The compressive strength of three different porosities (0.9, 1.8 and 3.6%) scaffolds 
was measured using universal testing machine (Tinius Olsen-H10KS) with a load cell of 
10kN. The cross-head speed was 1mm/min. The samples were subjected to loading till 80% 
deformation. The tests were performed in triplicate  and the mean values is reported (Fig 8). 
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Figure 8: Samples prepared for compression test (a) 0.9_TCA samples intriplicate (b) 1.8_TCA 
samples in triplicate and (c) 3.6_TCA samples in triplicate 
 
SBF was prepared by dissolving reagent-grade NaCl, NaHCO3, KCl, KH2PO4.3H2O, 
MgCl2.6H2O, CaCl2, Na2SO4 and trishydroxymethyl aminomethane (TRIS) into distilled 
water [67]. 1M HCl was used to maintain a pH of 7.4 at 37 ºC. The order and amount of 
reagents used to prepare 1000ml SBF is shown in Table 7. The samples were immersed in 
SBF (Fig 9 (a) and Fig 9 (b)) and then maintained at 37 ºC in a constant temperature water 
bath for 2 weeks and 4 weeks respectively. The samples are then taken out and air dried for 
further characterization. The dried samples are shown in Figure. Thereafter the samples were 
dried and the morphological assessment was done using SEM (JEOL JSM-6480LV). The X-
ray diffraction (XRD, PANalytical) studies were done using CuKα radiation at 30 kV and 15 
mA to analyze the phases of the scaffold. Scans were conducted between 10° to 60° angle at a 
scan speed of 3°/min.  
 
0.9_1 0.9_2 0.9_3 1.8_1 1.8_2 1.8_3 
3.6_1 3.6_2 3.6_3 
(a) (b) 
(c) 
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Table 7: Order and amount of reagents used for preparation of 1000 ml SBF 
Order Reagent Amount 
1 NaCl 58.40 
2 NaHCO3 84.006 
3 KCl 74.55 
4 K2HPO4.3H2O 228.22 
5 MgCl2.6H2O 203.30 
6 1.0-M-HCl - 
7 CaCl2 110.98 
8 Na2SO4 142.04 
9 Tris 121.13 
10 1.0-M HCl - 
 
 
 
Figure 9: (a) Samples maintained in 37°C in SBF for 2 weeks and 4 weeks, (b) Dried samples 
after immersion in SBF for 2 weeks and 4 weeks 
2 week SBF 4 week SBF 
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On dispensing the fibers into CaCl2-acetic acid bath a series of reactions take place. 
Firstly, the Ca
2+
 ions in the bath cross-link with the negatively charged alginate in the scaffold 
fibers. These ions are entrapped between two alginate chains which help in rapid setting of 
scaffold fibers. This cross-linking reaction depends on the concentration of Ca
2+ 
ions. 
Therefore, different concentrations of CaCl2 (0.2, 0.4 and 0.6 M respectively) were examined. 
0.4 M was chosen as the optimum CaCl2 concentration to give the scaffolds a desired height 
and shape. 0.2 M concentration showed a setting time of ~ 60 seconds and this time was very 
long for compression of scaffolds manually i.e the scaffolds take a long time to set so 
compression becomes difficult. In case of 0.6 M the cross-linking time is very less ~5-10 
seconds. This also poses a problem in fabrication as the time is so fast that the scaffold setd 
before the manual compression can be done. So ideally 0.4 M is chosen as it takes ~ 60 
seconds which has been found to be optimum for both cross-linking and compression of 
scaffolds. The various concentrations of CaCl2 and the corresponding setting time are shown 
in Table 8.  
Table 8:  Different calcium chloride concentrations and the corresponding cross-linking time of 
scaffold fibers 
Calcium chloride (CaCl2) Cross-linking time 
Molar (M) Seconds (s) 
0.2 ~60 
0.4 <60 
0.6 5-10 
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Different compositions and combinations of TCP: CMC was tried (Table 9). A ratio of 1:1 
TCP to CMC was taken in each case. Trials were performed for preparing 10 ml of paste. 
Initially 0.25 grams each of TCP and CMC were taken but it was seen that the paste was 
becoming to watery and the fibers were not taking a proper structure. When 0.5 grams of TCP 
and CMC was taken the paste had a good consistency which was easy for fiber extrusion. 
When 1 gram and above was taken the paste was becoming very thick and it was very 
difficult to dispense the fibers and no proper fiber formation occurred. So 0.5 grams each of 
TCP and CMC was used as an ideal amount for preparation of 10 ml paste. This particular 
amount resulted in fabrication of proper interconnected fibers inside the prepared bath. So the 
same amount of TCP and CMC powder was used for preparation of all the three scaffolds( 0.9 
%, 1.8 % and 3.6 %) respectively as shown in Table 10. 
 
Table 9:  Optimized composition of paste (10ml) (0.9 %NaHCO3) 
 
Alginate 
(Weight%) 
SPAN 80 
(Weight%) 
Sodium bicarbonate 
        (NaHCO3) 
        (Weight%) 
Tri-calcium 
phosphate 
Grams (g) 
Carboxymethyl 
cellulose 
Grams (g) 
2  1  0.9  0.25  0.25  
2  1  0.9  0.5  0.5  
2  1  0.9  1  1  
2  1  0.9  1.5  1.5  
 
Secondly, acetic acid in the bath reacts with NaHCO3 in the fiber releasing carbon 
dioxide gas. The reaction is as follows: 
NaHCO3 + CH3COOH= CH3COONa + CO2   + H2O 
The released gas is entrapped in scaffold fibers forming a closed porous structure. The 
surfactant acts as a foaming agent and helps in stabilizing the carbon-dioxide gas molecules. 
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Table 10:  Composition of paste (10ml) ( 0.6, 1.8, 3.6 %NaHCO3)  
 
Alginate  
(Weight%)  
SPAN 80  
(Weight%)  
Sodium 
bicarbonate 
(NaHCO3)  
(Weight%)  
Tri-calcium 
phosphate  
Grams (g)  
Carboxymethyl 
cellulose  
Grams (g)  
2  1  0.9  0.5  0.5  
2  1  1.8  0.5  0.5  
2  1  3.6  0.5  0.5  
 
The gas formed is removed by keeping the scaffolds in vacuum. This vacuum treatment forces 
the entrapped gas to be released such that closed pores are converted to open interconnected 
pores.  
 
 
Fig 10 (a) shows the SEM image of a scaffold fiber (0.9_TCA) with pore size ranging from 7-
10µm. The surface of the fiber is found to be rough. Surface roughness increases the surface 
area and this results in increase in apatite precipitation and protein absorption on the scaffold 
structure [32]. It also influences cell morphology, proliferation and differentiation [68]. Figure 
shows the low magnification image of the scaffold fibers. 0.9_TCA sample shows large 
number of pores all throughout the surface. The pore size in 0.9_TCA samples also is larger 
and clearly visible from the SEM image. The most important thing which can be noticed is 
that the pores are evenly distributed and more in number. On the other hand 1.8_TCA shows 
pores on its surface but it is lesser in number compared to the 0.9_TCA fibers (Fig ). The 
pores are not evenly distributed and are small in size compared to the previous ones. However 
overall a rough surface is clearly visible. In case of 3.6 _TCA fibers even lesser amount of 
pores is visible (Fig ). The surface is also less rough compared to the other two fibers. The 
surface of 3.6_TCA does not show much porosity and the surface roughness also seems to be 
lesser compared to the other two samples tested. 
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Figure 10: SEM images of fibers at low magnification (a) 0.9_TCA fibers, (b) 1.8_TCA fibers 
and (c) 3.6_TCA fibers 
 
From Fig 10, it is evident, that interconnectivity between the pores present in the fiber. The 
evolution of gas must have resulted in the formation of open interconnected pores. Cracks 
were observed at the edge of the pores which could be due to the following two reasons: 
1) Manual pressing down of scaffold fibers: The pressure applied during pressing causes an 
increased stress concentration on the pore edges which leads to crack formation.  
2) Uneven drying rate of scaffold in air: This creates stress in the fibers which show up as 
cracks during drying  
White pigmentation is visible throughout the Fig 11 (a) which is due to alginate present in the 
composite. Few areas show more number of pigmentation than others. This is due to non-
homogenous mixing of the composite suspension. Fig .11(b) shows the SEM image of a 
(a) (b) 
(c) 
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scaffold fiber (1.8_TCA) with higher amount of pore forming agent than the previous one 
(0.9_TCA). The figure revealed a highly porous microstructure with pore size less than 1µm. 
The number of pores formed in this case is higher when compared to 0.9_TCA samples. This  
is due to more amount of carbon-dioxide produced as a result of increased amount of 
NaHCO3. Thus, more gas is entrapped in 1.8_TCA fibers. There are few macroscopically 
visible fractographic features. This is due to the breakage of fiber under pressure. On 
increasing the concentration of NaHCO3 an interesting observation is made.  
 
                    
 
Figure 11: SEM images of scaffold (a) 0.9_TCA, (b) 1.8_TCA and (c) 3.6_TCA 
Although, the concentration of CO2 evolved is more, lesser pores are seen on the surface (Fig 
11 (c)).  In all these cases acetic acid is present in excess amount. But 0.9_TCA (Fig 11(a)) 
shows good pore morphology on its surface because the amount of CO2 entrapped is lesser. 
(a) (b) 
(c) 
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Hence, little shear is exerted to get the desired scaffold dimension. Whereas, higher CO2 
release in 1.8_TCA and 3.6_TCA renders the scaffold fibers fluffy. Therefore, more 
compression is required to achieve the same scaffold dimension, thereby affecting the surface 
pore morphology. Further, hardening occurs due to reaction of calcium and alginate. When 
there is an increase in amount of sodium bicarbonate, mole fraction of sodium alginate 
decreases which leads to a prolonged hardening time as observed in 1.8_TCA and 3.6_TCA. 
The scaffold fibers are not fully set while it is being compressed, which leads to disruption of 
pore formation on the surface.  
 
 Mercury intrusion porosimetry was used to evaluate the pore size distribution of the 
interconnected pores. The pore size has a wide range of distribution ranging from 0.01-495µm 
(0.9_TCA and 1.8_TCA) and 0.1 to 463 µm for 3.6_TCA samples respectively. The average 
pore size and pore volume percentage was calculated (Table 11).  
 
Table 11: Average pore diameter and average pore volume obtained from mercury intrusion 
porosimetry 
Sample code Average pore 
diameter (µm) 
Average pore 
volume (%) 
0.9_TCA 27.69 53.81 
1.8_TCA 26.94 57.39 
3.6_TCA 21.22 74.95 
 
All the samples showed almost the same pore diameter but the pore volume was found to 
increase with increasing percentage of pore forming agent. The pore size distribution for 
0.9_TCA, 1.8_TCA and 3.6_TCA is shown through a dv/dlogD vs pore size plot in Fig 12.   
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Figure 12: Pore distribution plot for (a) 0.9_TCA, (b) 1.8_TCA, (c) 3.6_TCA 
(c) 
(a) 
(b) 
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In 0.9_TCA plot (Fig 12(a)) the first peak is found on the extreme left, corresponding to 
intrusion in the range of 150-200 µm. When moved on to the right sharp peaks corresponding 
to 5-70 µm are evident. Further moving to right peaks corresponding to smaller diameters 
(.05-1µm) is visible. Peaks in the range of .007µm are observed at the extreme right. This is 
the consequence of the surface pores and the interconnected pores present in the interior of 
fibers. Fig 12(b) 1.8_TCA sample shows similar plot to the previous one but the number of 
peaks in 5-20µm range are more compared to others and a broad peak is observed in the range 
of 0.5-1µm. In Fig 12(c) 3.6_TCA plot highest peak is observed in the range of 0.5-200µm 
but very small peaks are observed in lower diameter range.As the mercury intrudes further 
from surface to the pores inside the fibers the diameter of pore reduces.  
 
  These MIP results in combination with the SEM micrographs suggest that micropores 
with average pore size of ~28µm are formed and this plays a very crucial role in bone 
formation. Microporosity initiates attachment of cells to scaffolds and allows bone ingrowth. 
It increases the retention of growth factors and induces angiogenesis [69]. 
 
The volume porosity of sample was evaluated using liquid displacement method. The 
measure porosity thus obtained in this method is the sum of micro and macopores. Figure 13 
shows the variation of porosity of different scaffold compositions namely 0.9_TCA, 1.8_TCA 
and 3.6_TCA. It can be clearly seen that initially the volume porosity is found to be 64.61%, 
71.40% and 72.05% for 0.9_TCA, 1.8_TCA and 3.6_TCA respectively. The increase in 
porosity can be attributed to the concentration of sodium bicarbonate. Table 12 shows the 
duplicate readings of the volume porosity obtained by this method.The measured scaffold 
porosity (0.9_TCA, 1.8_TCA and 3.6_TCA) is shown in Fig 13. With increase in 
concentration of sodium bicarbonate, the percentage of porosity was found to increase. 
Porosity enhances cell attachment and spreading due to following reasons: (a) increased 
surface area allows attachment of growth factors and enhances biomineralization. and bone 
growth; (b) interconnected porous structure increases diffusion of nutrients i.e. increases 
permeability and vascularization of scaffolds [69].  
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Figure 13: Graph showing percentage of porosity for various samples as measured by liquid 
displacement method 
      
 
 Table 12: Volume porosity as obtained by liquid displacement method 
Sample 
Code 
Va Vb Vc X 
(ml) (ml) (ml) (%) 
0.9_TCA 20 
20 
21 
21 
19.5 
18.32 
66.667 
62.57 
1.8_TCA 20 
20 
21 
21 
17.56 
20.27 
70.93 
71.88 
3.6_TCA 20 
20 
21.5 
21.5 
17.3 
20.65 
72.973 
71.112 
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The mechanical properties of scaffolds were evaluated by compression test. Studies 
show that mechanical strength of calcium phosphate-alginate scaffolds (CPC-alginate) is 
more compared to pure calcium phosphate scaffolds [70]. Although, CPC-alginate scaffolds 
showed favorable pore structure and properties suitable for bone tissue engineering, they are 
not suitable for load bearing applications [71]. In this study, carboxymethyl cellulose is added 
along with tri-calcium phosphate to increase the compressive strength of scaffold [72]. The 
stress vs strain data was obtained and fitted by power law model: 
 
 
 
Where σe and ϵe stand for engineering stress and engineering strain respectively. Parameters, k 
and n stand for rigidity constant and strain hardening index respectively. The strain hardening 
of a material is either due to densification of structure or due to high degree of polymer 
crosslinking. The stiffness of a material depends on its ‘k’ value and ‘n’ value gives the 
degree of concavity of the curve [73]. Table 13 summarizes the ϵe, σe, k and n values 
determined according to Power law equation. by nonlinear regression analysis (r
2
>0.99) via 
GraphPad Prism 5.0 (Trial version). The value of k was found to be around 0.31 for all the 
samples. When k=1 the material is said to be purely elastic and the material is purely 
viscoelastic when the value of k is equal to 0. Since the k value for the entire specimen lies 
between 0 and 1 the material is said to be viscoelastic. The n value is found to decrease as the 
concentration of sodium bicarbonate is increasing. The reason behind this is the cross-linking 
density is more in case of 0.9_TCA samples as the number of pores is less while the other two 
samples have higher pore volume percentage hence the degree of densification is less and 
hence the value of n is smaller compared to the rest. Also the graph shows an increase in 
concavity in case of 0.9_TCA samples and concavity decreases as the concentration of 
bicarbonate increases. That is we can say that the said material is a soft material.  The 
compressive strength of scaffolds is shown in Fig 14.  The stress vs strain curves for all three 
samples are shown in Fig 14. It was observed that 1.8_TCA scaffolds showed higher 
compressive strength as compared to others. Studies showed that compressive strength of  
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Table 13: K and n values obtained from regression analysis 
Sample code Log K n 
0.9_TCA 2.055±0.009 7.095±0.080 
1.8_TCA 2.077±0.064 4.312±0.055 
3.6_TCA 2.084±0.010 3.967±0.404 
 
 
Figure 14: Graph showing the compressive strength of 0.9_TCA, 1.8_TCA, 3.6_TCA samples 
 
fibrous scaffold depends on various parameters like fiber spacing, fiber diameter and layer 
thickness. Increase in fiber spacing decreases compressive strength of scaffold. In the present 
study the scaffolds were fabricated manually, so that the number of fibers per unit area is not 
consistent in every batch. As a result varied compressive strength is obtained. Further, 
bioactivity studies and swelling studies were carried out on 0.9_TCA as it had suitable pore 
architecture among the various samples. This is because with increase in fiber spacing the 
number of fibers per area decreases and hence the amount of loading area also reduces [74]. 
Hence on uniaxial loading different results are shown which could not be co-related. 
However, if the number of fibers could be controlled the mechanical strength can be analyzed. 
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Figure 15: Force vs extension curves obtained from compressive testing of (a) 0.9_TCA in 
triplicate, (b) 1.8_TCA in triplicate and (c) 3.6_TCA in triplicate 
The bioactivity studies of scaffolds (0.9_TCA) immersed in SBF for 2 weeks and 4 weeks is 
described in this section. The surface morphology and phase changes were observed and 
analyzed using SEM and XRD. After 2 weeks micron-sized crystals of various shapes were 
observed (Fig 16 (a)). The XRD plots of 0.9_TCA, 0.9_TCA immersed in SBF for 2 weeks 
and 4 weeks are shown in Fig 17. The 0.9_TCA samples show peaks of TCP approximately at 
2θ = 22°, 29°, 31° and 44° respectively. Peaks of hydroxyapatite were seen approximately at 
2θ = 26°, 32° and 34° respectively. SEM image of 4 weeks SBF immersed scaffolds showed 
thick, dense, spherical apatite like deposits (Fig 16 (b)). XRD studies show phase 
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transformation from TCP to HA have occurred. Thus, indicating that the fibers are 
mineralized on immersion in SBF.  
 
                
Figure 16: SEM images of SBF immersed samples of 0.9_TCA (a) 2 weeks and (b) 4 week 
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Figure 17: XRD plots of 0.9_TCA (a) before immersion in SBF, (b) 2 weeks, SBF and (c) 4 
weeks, SBF
(a) (b) 
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 In this particular study, a very simple and effective method was used to fabricate a three 
dimensional porous scaffold which has reasonable mechanical strength.. The scaffold fibres 
were formed as a result of forced extrusion of TCP-CMC and alginate solution into a CaCl2-
Acetic acid mixture. The fibres thus obtained were compressed a known dimension and these 
cylindrical scaffolds were vacuum treated. This resulted in release of CO2 and a porous 
scaffold was formed. Gas entrapment in the scaffold resulted in micro porosity in fibers. 
Subsequently, the vacuum treatment led to form an open interconnected porous network. 
Different ratios of alginate solution and TCP-CMC powder were mixed together to study the 
extrusion of the paste through the syringe. But the most optimal composition was determined 
to be 0.4 wt% .The surface of fibres were characterized using scanning electron microscopy. 
A white pigmentation was seen in 0.9_TCA scaffold which is due to the presence of alginate 
on its surface. Non- uniform mixing of the composite suspension caused more pigmentation 
in few areas as compared to the rest of the surface of the scaffold fibres. With increase in the 
amount of sodium hydrogen carbonate (0.9_TCA to 3.6_TCA) there was an increase in the 
amount of CO2 produced thus leading to entrapment of more gas in the fibers. However, 
0.9_TCA shows the best pore morphology on its surface when compared to the other 
compositions it is due to the fact that increase in CO2 entrapment makes the scaffold fibers 
fluffier and to get the desired scaffold dimension more compression is required. This affects 
the pores on the surface. Further, with increase in the amount of sodium bicarbonate, the 
concentration of sodium alginate decreases and this increases the hardening time considerably 
as observed in 1.8_TCA and 3.6_TCA scaffolds. Mercury intrusion porosimetry revealed the 
pore size distribution of the pores. The pore size ranged from 0.01-495 µm (0.9_TCA and 
1.8_TCA) and 0.1-463 µm (3.6_TCA) respectively. The average pore diameter was found to 
be ~27µm. The average pore size of ~27 µm suggests favourable attachment of cells to the 
scaffold fibers which is very crucial in osteogenesis. These scaffolds have favorable 3-D 
matrix for bone tissue engineering applications. The micro and macro porosity may help in 
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proper nutrient diffusion, cell attachment and growth. The volume porosity was obtained by 
liquid displacement method. It was found to be 64.61%, 71.40% and 72.05% for 0.9_TCA, 
1.8_TCA and 3.6_TCA respectively. With increase in bicarbonate concentration the overall 
pore volume percentage was found to increase significantly. Addition of CMC to the scaffold 
was done to increase the mechanical strength of the TCP composite. The mechanical 
properties were studied using the compression test. It was seen that 1.8_TCA showed higher 
compressive strength compared to the other compositions. The regression analysis was done 
for stress vs strain curve. Rigidity constant was found to be 2.05, 2.07 and 2.084 for 
0.9_TCA, 1.8_TCA and 3.6_TCA respectively. The strain hardening index was calculated to 
be 7.05, 4.312 and 3.967 for all the three compositions. The mechanical tests showed varied 
results due to inconsistency in scaffold fabrication as the number of fibers per unit area varied 
in each batch. This drawback can be overcome if a well defined 3-D matrix is fabricated using 
automated tools. The scaffolds showed good in-vitro bioactivity on immersion in SBF as the 
formed phase was similar to bone mineral phase. In particular, peaks of TCP and 
Hydroxyapatite were seen at 2θ= 22°, 29°, 31° and 44° and 2θ=.26°, 32° and 34° respectively. 
Thus, indicating that phase transformation from TCP-HA has occurred and mineralization has 
taken place on the fibers. These properties make these scaffolds an ideal material for tissue 
engineering constructs. Further research in this direction will make TCP-CMC-alginate 
scaffolds as an ideal material for stimulating bone regeneration and revolutionize the field of 
bone tissue engineering.  
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